title: A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas.
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis.
authors.forename: Lauren R
authors.initials: LR
authors.lastname: Becker
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis.
authors.forename: Angela E
authors.initials: AE
authors.lastname: Aakhus
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis.
authors.forename: Hilary C
authors.initials: HC
authors.lastname: Reich
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis.
authors.forename: Peter K
authors.initials: PK
authors.lastname: Lee
mesh_terms: D000813:Anilides / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011725:Pyridines / Q000008:administration & dosage*; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000813:Anilides; C538724:HhAntag691; D011725:Pyridines